ARRAY Technologies, Inc. Reports Financial Results for the Second Quarter 2025

ARRAY Technologies, Inc. Reports Financial Results for the Second Quarter 2025 Commercial excellence continues to deliver, year-to-date volume growth up 84% over 2024 GlobeNewswire August 07, 2025 2025 Second Quarter Highlights Revenue of $362.2 million Gross Margin of 26.8% Adjusted gross margin(1) of 27.8% Net income to common shareholders of $28.5 million Adjusted EBITDA(1) of […]

Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion.

Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire August 07, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Revenues increased 18% compared to same period last year U.S. revenue increased 57% compared to same period last year Net loss per share decreased 43% compared to same period last year BOULDER, COLORADO / ACCESS Newswire / August 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based

Eric Bolton Joins Ryman Hospitality Board of Directors

(NYSE:RHP),(NYSE:MAA),(NYSE:EGP), NASHVILLE, Tenn., Aug. 07, 2025 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, announced that veteran REIT executive Eric Bolton has been appointed to its Board of Directors (the “Board”), effective today.

NWPX Infrastructure, Inc. Announces Second Quarter 2025 Financial Results

— Net sales of $133.2 million, a Company record under its current operating segments, increased 2.8% year-over-year — Record net sales of $48.6 million for the Precast Infrastructure and Engineered Systems segment (“Precast”) — Net income of $0.91 per diluted share — Backlog1 of $298million for the Water Transmission Systems segment (“WTS”); backlog including confirmed

VIAVI Announces Fiscal Fourth Quarter and Fiscal Year 2025 Results

VIAVI (NASDAQ: VIAV) today reported results for its fiscal fourth quarter and fiscal year ended June 28, 2025 with the following highlights. https://mma.prnewswire.com/media/386858/Viavi_Logo.jpg Fiscal Fourth Quarter — Net revenue of $290.5 million, up $38.5 million or 15.3% year-over-year — GAAP operating margin of 5.3%, up 760 bps year-over-year — Non-GAAP operating margin of 14.4%, up

Nektar Therapeutics Reports Second Quarter 2025 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2025. https://mma.prnewswire.com/media/1390052/nektar_logo.jpg Cash and investments in marketable securities on June 30, 2025 were $175.9 million as compared to $269.1 milliononDecember 31, 2024. Nektar's cash and marketable securities at June 30, 2025 do not include $107.5 million of approximate net proceeds

FS Credit Opportunities Corp. (FSCO) Declares Distribution for August 2025

The Board of Directors of FS Credit Opportunities Corp. (the Fund) (NYSE: FSCO) announced the monthly distribution for August 2025. The distribution of $0.0678 per share will be paid on August 29, 2025. Further information on the distribution is summarized in the charts below. https://mma.prnewswire.com/media/2734659/Future_Standard_Logo.jpg The current annualized distribution rate equates to an annualized distribution

Erie Indemnity Reports Second Quarter 2025 Results

Net Income per Diluted Share was $3.34 for the Quarter and $5.99 for the Six Months of 2025 Erie Indemnity Company (NASDAQ: ERIE) today announced financial results for the quarter and six months ending June 30, 2025. Net income was $174.7 million, or $3.34 per diluted share, in the second quarter of 2025, compared to

Scroll to Top